Conversion Therapy Bans: Protection or Overreach?

The phrase “conversion therapy” tends to end conversations before they even begin. It’s one of those terms that carries so much emotional and cultural weight that people often feel they already know where they’re supposed to land. Harmful. Discredited. Case closed. But once you slow down and actually examine what’s being debated—laws that prohibit certain…

Medicare by Choice: Smart Reform or Slow-Motion Takeover?

At its core, “Medicare by Choice” is an attempt to thread one of the most politically delicate needles in American policy: how to expand access to affordable healthcare without detonating the existing system in the process. Instead of replacing private insurance outright, the proposal would allow any American—regardless of age—to voluntarily enroll in Medicare. Employers…

The Abortion Pill Showdown: Should Congress Override the FDA on Mifepristone?

Last week, Hawley introduced legislation that would remove the U.S. Food and Drug Administration’s approval for mifepristone, the first pill used in the two-drug medication abortion regimen. Hawley argues the drug is unsafe and that regulators ignored mounting evidence of complications. Critics say the proposal is little more than political theater aimed at restricting abortion…

America’s Childhood Obesity Crisis: You Can’t Inject Your Way Out of a Cultural Problem

America’s childhood obesity problem didn’t appear overnight, and it certainly won’t disappear because of a trendy new injection. Yet that seems to be where the conversation is heading. A growing debate is unfolding around the Trump administration’s “Make America Healthy Again” (MAHA) initiative and the increasing push to use GLP-1 drugs—medications like Ozempic and Wegovy—to…

Why Cutting Federal Funding for Gender-Affirming Care Is the Right and Necessary Step

The federal government’s recent move to restrict Medicare and Medicaid funding for so-called “gender-affirming care” for minors has ignited predictable outrage. Activists describe it as discriminatory. Advocacy groups frame it as a moral emergency. Critics accuse policymakers of ignoring “settled science.” But beneath the noise is a quieter, more sobering reality: for the first time…

A Reflection on the GOP’s Health-Care Rift

Washington, D.C., never lacks for drama, but every now and then the Republican caucus serves up an episode spicy enough to make daytime television blush. This time, the plot centers on something far more consequential than committee assignments or who accidentally unplugged the espresso machine in the Capitol cafeteria. House Republicans have found themselves in…

Washington Could Use a Little More Light and a Lot More Honesty

If you’ve glanced at the headlines lately, you’ve probably noticed a theme: Washington is allergic to transparency. Whether we’re talking about the Epstein files, the longest shutdown in American history, questionable investigations into political opponents, violence against federal officials, senators collapsing from undisclosed medical issues, or a congressman now facing mortgage-fraud allegations, it’s all pointing…

A Tangled Ruling with Real-World Stakes

Yesterday, the Supreme Court handed down a razor-thin 5–4 decision that allows the Trump administration to move forward with its plan to pause—or even fully terminate—roughly $783 million in NIH grants. These aren’t small, obscure projects either. We’re talking about research on women’s health, HIV prevention, suicide and mental health interventions, real-world studies that deal…